Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ: CMPS )

4.570 +0.150 (+3.39%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,309,989
Open 4.420
Bid (Size) 4.600 (3)
Ask (Size) 4.620 (20)
Prev. Close 4.420
Today's Range 4.360 - 4.639
52wk Range 3.165 - 12.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months
Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca. 
Via Stocktwits
RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks. 
Via Investor's Business Daily

Performance

YTD
+10.12%
+10.12%
1 Month
+34.02%
+34.02%
3 Month
-1.93%
-1.93%
6 Month
-35.18%
-35.18%
1 Year
-56.52%
-56.52%

More News

Read More
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
From Compass Pathways plc
Via Business Wire
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
From Compass Pathways plc
Via Business Wire
Uncovering Potential: Compass Pathways's Earnings Preview
Via Benzinga
Compass Pathways Announces Pricing of Underwritten Offering
From Compass Pathways plc
Via Business Wire
Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)
From Compass Pathways plc
Via Business Wire
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
Via The Motley Fool
Compass Pathways to Participate in December Investor Conferences
From Compass Pathways plc
Via Business Wire
COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What's Next For This Psychedelics Co?
Via Benzinga
Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday
Via Benzinga
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
Via Investor's Business Daily
Topics Government
Exposures Political
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
Via Benzinga
Exposures Product Safety
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Top 3 Health Care Stocks You'll Regret Missing In November
Via Benzinga
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
Via Benzinga
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results
Via Benzinga
Exposures Fossil Fuels
Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
From Compass Pathways plc
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
From Compass Pathways plc
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.